A Persuasive mHealth Application for Improving Patient Psychosocial Supports for Opioid Prescription Adherence and Tapering

Opioid overdoses now account for 18,364 (17.2% of all) hospitalizations in Ontario and related mortality has increased by 242% since 1991. These have been associated with a 23% increase in high-dose prescribing and increased consumption of opioids over the past two decades. Although patients identify opioid use reduction as an important outcome of their pain management, only a small portion discontinue use of their high-dose prescriptions. Resolving the barriers to successful dose reduction can play an important role in decreasing the chronic disease burden associated with prescription opioids

The overall objective of this projectis to explore the early feasibility and acceptability of an mhealth-based behavioural intervention technology in opioid prescribed, chronic pain patients in Ontario who are interested in mHealth support. This will inform the iterative developmentand testingof MIToc, a Proof-of-Concept mHealth application.

Students:

Dr. Raad Yameen

HBSc, MD, MHScTR

Capstone Supervisor:

Prof. Joseph Ferenbok

PhD
Translational Research Program, Temerty Faculty of Medicine, University of Toronto
Revolutionary Translator, Director

Capstone Advisory Committee:

Peter Selby

CAMH

Clinician Scientist, Addictions Division and Chief of Medicine

Jonathan Rose

PhD

Department of Political Studies | Queen's University

Associate Professor

Dr. Andrea Furlan

MD, PhD

Division of Physiatry, Department of Medicine, Faculty of Medicine, University of Toronto, Toronto Rehabilitation Institute (TRI) , Institute for Work & Health, Institute of Medical Sciences, Temerty Faculty of Medicine, University of Toronto

Associate Professor, Scientist

A Persuasive mHealth Application for Improving Patient Psychosocial Supports for Opioid Prescription Adherence and Tapering

Dr. Raad Yameen

HBSc, MD, MHScTR

Opioid overdoses now account for 18,364 (17.2% of all) hospitalizations in Ontario and related mortality has increased by 242% since 1991. These have been associated with a 23% increase in high-dose prescribing and increased consumption of opioids over the past two decades. Although patients identify opioid use reduction as an important outcome of their pain management, only a small portion discontinue use of their high-dose prescriptions. Resolving the barriers to successful dose reduction can play an important role in decreasing the chronic disease burden associated with prescription opioids

The overall objective of this projectis to explore the early feasibility and acceptability of an mhealth-based behavioural intervention technology in opioid prescribed, chronic pain patients in Ontario who are interested in mHealth support. This will inform the iterative developmentand testingof MIToc, a Proof-of-Concept mHealth application.

Capstone Supervisor:

Prof. Joseph Ferenbok

PhD
Translational Research Program, Temerty Faculty of Medicine, University of Toronto
Revolutionary Translator, Director

Capstone Advisory Committee:

Peter Selby

CAMH

Clinician Scientist, Addictions Division and Chief of Medicine

Jonathan Rose

PhD

Department of Political Studies | Queen's University

Associate Professor

Dr. Andrea Furlan

MD, PhD

Division of Physiatry, Department of Medicine, Faculty of Medicine, University of Toronto, Toronto Rehabilitation Institute (TRI) , Institute for Work & Health, Institute of Medical Sciences, Temerty Faculty of Medicine, University of Toronto

Associate Professor, Scientist